Eli Lilly Ends Coronavirus Antibody Treatment Trial, Other Studies Go On
Eli Lilly & Co. is ending a clinical trial of its antibody drug in hospitalized COVID-19 patients after federal researchers concluded the therapy doesn't work on them. The study of…
